PALB2 and familial pancreatic carcinoma: Recently, the ACMG published a guideline for patients with germline variants in PALB2, in which risk-reducing mastectomy is an option to be considered to reduce BC risk as well as to include surveillance for pancreatic cancer; however, oophorectomy is not recommended for patients below 50 years.